CompuGroup Medical SE: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback CompuGroup Medical SE: Release of a capital market information 21.12.2018 / 10:29 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 1st Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, December 21, 2018 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 1st Interim Announcement In the period from December 17, 2018, up to and including December 20, 2018, CompuGroup Medical SE has bought back a total of 31,300 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on December 17, 2018. The overall volume of the shares bought back daily in the period from December 17, 2018, up to and including December 20, 2018, and the daily volume-weighted average stock market prices of the shares are as follows: Date Overall volume of Volume-weighted average shares bought back stock market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) December 17, 2018 10,400 38.7742 December 18, 2018 10,900 41.3958 December 19, 2018 4,000 41.4750 December 20, 2018 6,000 40.3237 In total: 31,300 40.3293 The total number of shares which have been bought back so far by CompuGroup Medical SE since December 17, 2018, up to and including December 20, 2018, within the framework of the share buyback program thus amounts to 31,300 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, December 21, 2018 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 21.12.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

761407  21.12.2018